Cholinergic Agonists Added to Virginia TPA-Formulary
Summary
The Virginia Board of Optometry completed the regulatory process to add cholinergic agonists to the TPA-Formulary effective May 25, 2022. Under 18VAC105-20-47, TPA-certified optometrists may now procure, administer, and prescribe cholinergic agonists as Schedule VI topical agents to treat diseases and abnormal conditions of the human eye and its adnexa.
What changed
The Virginia Board of Optometry has formally added cholinergic agonists as a permitted category of therapeutic pharmaceutical agents in the TPA-Formulary under 18VAC105-20-47. This regulatory update expands the scope of medications that TPA-certified optometrists may prescribe to include cholinergic agonists as Schedule VI topical agents for treating conditions of the eye and adnexa.
Affected parties, specifically TPA-certified optometrists in Virginia, will have expanded prescribing authority for this category of drugs effective May 25, 2022. Pharmaceutical manufacturers and distributors of cholinergic agonists may see increased utilization in the optometric setting as a result of this formulary addition.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Virginia Board of Optometry REGULATORY UPDATE TO TPA-FORMULARY The Board of Optometry has completed the regulatory process to add cholinergic agonists to the TPA-Formulary. Effective May 25, 2022, cholinergic agonists may be prescribed by a TPA-Certified Optometrist per the Regulations of the Virginia Board of Optometry that states the following: 18VAC105-20-47. Therapeutic pharmaceutical agents.
A TPA-certified optometrist, acting within the scope of his practice, may procure,
administer, and prescribe medically appropriate therapeutic pharmaceutical agents (or any therapeutically appropriate combination thereof) to treat diseases and abnormal conditions of the human eye and its adnexa within the following categories:Topically administered Schedule VI agents:
Cholinergic agonists;
Please direct questions to optbd@dhp.virginia.gov Board of Optometry
Named provisions
Related changes
Get daily alerts for VA Optometry Board
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from VA Optometry Board.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when VA Optometry Board publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.